Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
1992-2-14
|
pubmed:abstractText |
We investigated the role of transforming growth factor beta 1 (TGF-beta 1) in growth regulation of the murine osteoblastic cell line, MC3T3-E1. We detected TGF-beta activity in the conditioned medium of MC3T3-E1 cells and its activity was increased by acid treatment of the bioassay system using CC1 64 cells. Northern blot analysis revealed the expression of TGF-beta 1 precursor messenger ribonucleic acid (mRNA). MC3T3-E1 cells possessed a single class of high affinity TGF-beta 1 receptor (2.8 x 10(4) sites per cell, Kd = 196 pM). Cross-linking studies revealed three specific TGF-beta receptors with molecular masses of 65, 95 and 280 kDa. Both TGF-beta and epidermal growth factor (EGF) stimulated [3H]-thymidine incorporation into cells. EGF decreased the number of TGF-beta receptor dose-dependently, and pretreatment of cells with 10 nM EGF attenuated cell growth by TGF-beta. All these data suggested that TGF-beta might be an autocrine growth factor in murine osteoblastic MC3T3-E1 cells and that EGF might modulate the growth of cells by down-regulating the TGF-beta receptor level.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/DNA,
http://linkedlifedata.com/resource/pubmed/chemical/Epidermal Growth Factor,
http://linkedlifedata.com/resource/pubmed/chemical/RNA, Messenger,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Cell Surface,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Transforming Growth...,
http://linkedlifedata.com/resource/pubmed/chemical/Thymidine,
http://linkedlifedata.com/resource/pubmed/chemical/Tritium
|
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0169-6009
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
15
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
125-35
|
pubmed:dateRevised |
2003-11-14
|
pubmed:meshHeading |
pubmed-meshheading:1662554-Animals,
pubmed-meshheading:1662554-Blotting, Northern,
pubmed-meshheading:1662554-Cell Division,
pubmed-meshheading:1662554-Cells, Cultured,
pubmed-meshheading:1662554-DNA,
pubmed-meshheading:1662554-Dose-Response Relationship, Drug,
pubmed-meshheading:1662554-Down-Regulation,
pubmed-meshheading:1662554-Epidermal Growth Factor,
pubmed-meshheading:1662554-Mice,
pubmed-meshheading:1662554-Mice, Inbred C57BL,
pubmed-meshheading:1662554-Osteoblasts,
pubmed-meshheading:1662554-RNA, Messenger,
pubmed-meshheading:1662554-Receptors, Cell Surface,
pubmed-meshheading:1662554-Receptors, Transforming Growth Factor beta,
pubmed-meshheading:1662554-Thymidine,
pubmed-meshheading:1662554-Tritium
|
pubmed:year |
1991
|
pubmed:articleTitle |
Epidermal growth factor attenuates cell proliferation by down-regulating the transforming growth factor-beta receptor in the osteoblastic cell line MC3T3-E1.
|
pubmed:affiliation |
Department of Obstetrics and Gynecology, Osaka University Medical School, Japan.
|
pubmed:publicationType |
Journal Article
|